Company: FENC
Filing Date: 2025-11-18
Form Type: S-8
Source: 0001104659-25-113660
Chunk: 5

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-11-18
Form: S-8
Chunk 5
---
 or expenses related
to, the proceeding; and (4) “expenses” has the meaning set out in the Business Corporations Act (British Columbia).

Our Articles provide that
the Company may purchase and maintain insurance for the benefit of any person (or his or her heirs or legal personal representatives)
who is or was a director, alternative director, officer, employee or agent, or held or holds such position or a position equivalent to
the foregoing (each, an “insured party”) with respect to (i) the Company; (ii) a corporation at a time when the
corporation was an affiliate of the Company; (iii) at the request of the Company, served in such capacity with respect to a corporation,
partnership, trust, joint venture or other unincorporated entity, against any liability that may be incurred by him or her acting in
such capacity.

We maintain liability insurance
policies regarding our directors and officers against certain liabilities that they may incur in such capacities.

Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing
provisions, we have been informed that in the opinion of the Commission such indemnification is against public policy as expressed in
the Securities Act and is therefore unenforceable.

Item 7. Exemption From Registration Claimed.

Not applicable.

Item 8. Exhibits.

| Exhibit No. 
 4.1         
 4.2         |     | Description                                                                                                                           
 of Exhibit                                                                                                                            
 Notice                                                                                                                                
 of Articles dated August 25, 2011 (incorporated herein by reference to Exhibit 3.2(i) to our Form 8-K filed August 26,                
 2011).                                                                                                                                
 Articles                                                                                                                              
 dated August 25, 2011 (incorporated herein by reference to Exhibit 3.2(ii) to our Form 8-K filed August 26,                           
 2011).                                                                                                                                |
|:------------|:----|:--------------------------------------------------------------------------------------------------------------------------------------|
| 4.3         |     | Notice                                                                                                                                
 of Alteration dated September 3, 2014 (incorporated herein by reference to Exhibit 3.1 to our Form 8-K filed September 9,             
 2014).                                                                                                                                |
| 4.4         |     | Shareholder                                                                                                                           
 Rights Plan Agreement dated June 27, 2017 between Fennec Pharmaceuticals Inc. and Computershare Trust